These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15008298)

  • 1. Experience in the use of radioactive iodine therapy for hyperthyroidism in Nigerian patients. A study of twenty-two patients.
    Agboola-Abu CF; Kuku SF
    West Afr J Med; 2003 Dec; 22(4):324-8. PubMed ID: 15008298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome after standardized versus dosimetric radioiodine treatment of hyperthyroidism: an equivalence study.
    Kok SW; Smit JW; de Craen AJ; Goslings BM; van Eck-Smit BL; Romijn JA
    Nucl Med Commun; 2000 Nov; 21(11):1071-8. PubMed ID: 11192714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the long-term efficacy of low dose 131I versus antithyroid drugs in the treatment of hyperthyroidism.
    Chen DY; Jing J; Schneider PF; Chen TH
    Nucl Med Commun; 2009 Feb; 30(2):160-8. PubMed ID: 19194213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis.
    Goolden AW; Stewart JS
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):217-22. PubMed ID: 3708873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
    Jarløv AE; Hegedüs L; Kristensen LO; Nygaard B; Hansen JM
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):325-9. PubMed ID: 7586602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioactive iodine in the treatment of Graves' disease.
    Al-Kaabi JM; Hussein SS; Bukheit CS; Woodhouse NJ; Elshafie OT; Bererhi H
    Saudi Med J; 2002 Sep; 23(9):1049-53. PubMed ID: 12370710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
    Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic 131I dose in hyperthyroidism: role of pretreatment with thionamide.
    Kabadi U; Cech R
    Thyroidology; 1994 Dec; 6(3):87-92. PubMed ID: 7545000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioactive iodine therapy in Graves' hyperthyroidism].
    Andrade VA; Gross JL; Maia AL
    Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):159-65. PubMed ID: 15611828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs.
    Koornstra JJ; Kerstens MN; Hoving J; Visscher KJ; Schade JH; Gort HB; Leemhuis MP
    Neth J Med; 1999 Nov; 55(5):215-21. PubMed ID: 10593131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [131I-therapy of Basedow's disease and nonimmunogenic hyperthyroidism].
    Hoeschel M; Heinze HG
    Nuklearmedizin; 1984 Jun; 23(3):143-9. PubMed ID: 6548309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of treatment of thyrotoxicosis by three different methods.
    Franklyn JA; Daykin J; Drolc Z; Farmer M; Sheppard MC
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):71-6. PubMed ID: 2004475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.